Opus Genetics, Inc.: cashflow_financing
| Value | {"amount": 21371000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-06-30 |
| Status | current |
| Entity | Opus Genetics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:00:05.893770+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/056c8d73-01bb-4a7a-bf71-07089b7cdd8d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001140361-25-030836Retrieved: 2026-08-19T12:00:05.893770+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001228627/cashflow-financing/2025-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/056c8d73-01bb-4a7a-bf71-07089b7cdd8d
History
- no predecessors — first report